• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ARX 0.92% 54.0¢

AROA BIOSURGERY LIMITED - News & Media

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures,... Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement and complex wounds. Its subsidiaries are Aroa Biosurgery Incorporated and Mesynthes Nominee Limited.More

No News & Media currently available.

(20min delay)
Last
54.0¢
Change
-0.005(0.92%)
Mkt cap ! $185.8M
Open High Low Value Volume
55.0¢ 55.0¢ 53.0¢ $210.2K 388.8K

Buyers (Bids)

No. Vol. Price($)
1 4 53.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 11062 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
54.5¢
  Change
-0.005 ( 0.93 %)
Open High Low Volume
54.0¢ 55.5¢ 53.0¢ 112963
Last updated 15.51pm 06/05/2024 ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.